WilPharma Main Server Room — Sub-Level 3 | October 4, 2005 | 15:51
The server room was cool and humming and had the quality of institutional order that persisted even when everything above it was not orderly.
Alen holstered the USP and moved to the primary terminal. The system was running on backup power — the main network was cycling through lockdown protocol, which meant the external connections were down, which meant he had a local-access window before the system completed its data sequestration routine. He plugged in the Section Q drive and began working.
His fingers moved fast. Not dramatically fast — he had no audience, and he was not performing — but fast in the specific way that came from understanding the system's architecture before touching it, from having read the WilPharma network specifications in the Section Q briefing package and built a navigation map of the relevant directories in advance. He was not hacking. He was finding things he already knew the address of.
The encryption was Level 5 — better than he had expected from the briefing, which had predicted Level 3. Someone in WilPharma's IT architecture had upgraded this system in the past six months and had not communicated that upgrade through channels that the intelligence services could read. He noted this as relevant and spent forty-seven seconds on the bypass, which was longer than the briefing had allocated.
Then the data.
He read quickly. He had been trained to read quickly and his baseline comprehension speed was not something the training had needed to work hard on. The files populated the screen and he moved through them with the systematic attention he brought to everything important.
What he found was worse than the briefing had indicated.
The vaccine program was real — the research was genuine, the methodology was sound, WilPharma had actually been developing a functional T-Virus countermeasure. That part of the public story was true. But layered underneath the vaccine research, accessible only through the secondary server partition that the Section Q device had just opened, was the other program. The one that used the vaccine program as cover, as funding, as a reason to maintain active viral samples in a controlled research environment.
Subject manifests. Countries. Numbers.
He read them without letting his face do anything, which was discipline he had been practicing his whole life.
Subject 455: Failed. Tissue rejection. T-Virus strain Delta.
Subject 456: Success. Aggressive cellular modification. Intelligence retention: Minimal. Viable as tactical asset.
There were four hundred and twelve entries above Subject 455. He did not read all of them. He had the data drive recording the full archive and he had the abstract of what this represented, which was that Downing had been running live field tests in multiple countries for at least three years, categorizing the results, building a performance profile for a product he intended to sell to a buyer who wanted proof of concept at scale.
"They aren't curing it," he said. Quietly. Not for the comms. For himself. "They're grading it."
He found the Golgotha file.
Project Golgotha. G-Virus. The sub-folder labeled
Curtis Miller — Test Subject: Active
caught him for a second — not long, but a second. Someone in this building was currently carrying an active G-Virus infection, which meant the structural situation in the facility was about to change in a very specific and very bad direction. He logged this, flagged it to comms, and kept downloading.
The drive indicator: 40%. 60%.
The sound from above was heavy-caliber. Shotgun, standard twelve-gauge, the specific acoustic signature of an operator working through a building with a weapon suited for corridor engagements. Kennedy. Moving down through the building, toward the garden level, drawing everything in the facility with him.
On the security feed that the terminal was still displaying: Leon Kennedy and a woman he recognized from the file — Claire Redfield, TerraSave — moving through the atrium. They were not being subtle. They were doing what Kennedy's file described him doing: establishing presence, absorbing response, clearing a path.
On another feed: a suited figure moving fast through the lower east corridor with a briefcase, heading toward an exit that the building's emergency schematic placed at the back of the parking structure. Frederic Downing. The G-Virus data and the viral samples. Moving toward his extraction before the building came down.
Alen tapped comms.
"Control. High-value target moving through Lower East corridor toward parking extraction. Confirmed visual on Downing. He has the samples. Requesting permission to intercept."
The pause before Briggs responded was three seconds, which was long for Briggs.
"Negative, Phantom." The voice was flat and final. "Digital archive is the priority. Downing's arrest is Kennedy's operation — AUPIT has jurisdiction on the physical evidence. If you intercept, you expose yourself to Kennedy and the WilPharma security footage. The intelligence chain breaks." A pause. "You get us the digital trail. Let AUPIT handle the rest."
Alen watched the feed. Downing's figure moving down the corridor. The briefcase. Seven years of building toward this moment — the classified folder, the newspaper in the plastic sleeve, the progression from Raccoon City to The Nursery to this server room — and Downing was forty meters away through two walls and one security door.
He thought about Holloway's file. About the Tricell footnote that Section Q had included in the WilPharma briefing, the reference to a corporate entity that was beginning to appear at the edges of post-Umbrella viral research with an interest in surviving assets. He thought about the word
catalogue
and what would happen to Downing's catalogue after Downing was arrested and the legal process took two to five years.
He thought about Jessica.
Science failed them. Protocols failed.
"Copy," he said.
The drive: 80%. 95%.
Download complete.
He yanked the drive. Pocketed it. Stood up from the terminal and turned around.
Two men in the doorway. Not infected — the posture was wrong for infected, too purposeful, too coordinated. Private security, the kind WilPharma would have retained for exactly this scenario: cleanup personnel, activated when the containment situation became unmanageable, with standing orders to clear the server room.
The first one opened his mouth.
Alen closed the distance before the word completed.
Left hand on the rifle barrel, redirecting upward — the shot that discharged went into the ceiling tiles and produced exactly the sound he had wanted to avoid but had planned for anyway. Right palm to the chin, controlled force, the head snapping back, the body following the physics of a system suddenly without a vertical reference point. The first man went down and Alen was already rotating, the body between him and the second man, a human shield that cost him nothing and cost the second man the clean shot he needed.
The second man hesitated. That was the moment — the half-second of trained assessment before an untrained response — and Alen used it.
Two rounds. Suppressed. The sound was the mechanical action and the impact and the particular quiet that followed both.
The second man went down.
Alen stood for four seconds, listening to the building. The shotgun above had stopped. Either Kennedy had reached his objective or the situation had changed; either way, his window for exit was contracting. He holstered the USP, stepped over the guards, and moved toward the maintenance access point.
He thought about Downing, somewhere below in the parking structure.
He thought about the data drive in his jacket pocket.
Let AUPIT handle the physical evidence.
Kennedy would handle it. Kennedy was very good at handling things. His file was entirely clear on that.
Alen moved toward the exit and did not look back at the server room, and did not think about Downing again, and the drive was in his pocket and the mission was complete and the building was going to be someone else's problem in approximately the next eight minutes.
"Phantom is withdrawing," he said into the comms. "Data secured. Exiting the structure."
Briggs: "Confirmed. Kennedy is in the garden level — the G-Virus situation is developing. Extract before the military cordon closes."
He extracted.
He did not stay to watch what developed in the garden level, because watching was not his function and because the garden level was Kennedy's, and because some part of him that he did not examine in real time understood that watching a man fight a G-mutant that Downing had created as a product demonstration — a man whose name was Curtis Miller, who had a sister in the building, who had not made this choice — was not something he wanted to carry alongside everything else he already carried.
He walked out of WilPharma's service entrance at 16:23, into an industrial district that smelled of October and smoke from the airport three kilometers east, and he walked two blocks north and flagged a cab with his free hand and told the driver an address that was not where he was going and paid in cash and got out four blocks later and walked the rest of the way to the extraction point that Briggs had designated.
He sat in the extraction vehicle for thirty-six minutes waiting for the driver to arrive, with the drive in his jacket pocket and his hands in his lap and the sound of sirens in the distance that were going to be going for a long time.
He thought about Downing, who would be arrested within the next two hours. About the G-Virus samples that Kennedy would recover from whatever the containment situation produced. About Tricell, which was going to be purchasing WilPharma's assets within the next six months at a price that reflected a distressed sale, and which had interests in certain types of research that the WilPharma briefing had flagged as a concern worth noting.
He thought about the word
catalogue.
About what happened to catalogues when the person who built them was arrested and the legal process ran its course and the assets changed hands.
He took the drive out of his pocket and held it.
He had what he came for. He had done what the mission required. He had been a scalpel and he had left no scar, and Kennedy would close the public-facing operation, and Downing would confess, and the official record would say the right things.
And Tricell would buy WilPharma.
He put the drive back in his pocket and looked out the extraction vehicle's window at the smoke on the horizon and made a note in the part of his mind that kept notes on things that were going to require returning to.
Tricell.
The driver arrived. They left.
END OF CHAPTER TWENTY-THREE
Chapter Twenty-Four to follow — Operation WINTER HARVEST: After-Action Review